Today Swiss Re is announcing its intention to sell elipsLife and to enter a strategic partnership with Swiss Re's long-standing client Swiss Life International. The transaction is expected to be completed in the first half of 2022, subject to regulatory approval and merger control clearance by the applicable authorities.
Since 2008, elipsLife, a wholly-owned subsidiary of Swiss Re, has developed into an international biometric insurance company, delivering high quality services to its partners and customers.
The elipsLife team is looking forward to continue working with its brokers, customers and business partner and is committed to providing its services.